Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
PaperCitations, authors & open-access status
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 224 citations, 2020 year and bronze oa status.
224
Citations
2020
Year
bronze
OA Status